Lourdes Felix
Directeur Général chez BIOCORRX INC.
Fortune : 117 791 $ au 30/04/2024
Postes actifs de Lourdes Felix
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOCORRX INC. | Directeur/Membre du Conseil | 07/03/2013 | - |
| Directeur Général | 09/11/2020 | - | |
| Directeur des opérations | - | - | |
| Directeur Financier/CFO | 01/10/2012 | - | |
| Comptroller/Controller/Auditor | - | 02/03/2020 | |
| President | 26/02/2020 | 09/11/2020 | |
| Treasurer | 01/10/2012 | 17/06/2016 | |
| SIYATA MOBILE INC. | Directeur/Membre du Conseil | 29/10/2021 | - |
| Independent Dir/Board Member | 29/10/2021 | - | |
| LICHEN CHINA LIMITED | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| AVALON GLOBOCARE CORP. | Directeur/Membre du Conseil | 09/01/2023 | - |
| Independent Dir/Board Member | 09/01/2023 | - | |
| LA ROSA HOLDINGS CORP. | Directeur/Membre du Conseil | 19/04/2024 | - |
| Independent Dir/Board Member | 19/04/2024 | - | |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Directeur/Membre du Conseil | - | - |
| Directeur des opérations | - | - | |
| Directeur Financier/CFO | - | - | |
| Fondateur | - | - | |
| President | - | - | |
Vocodia Holdings Corp.
 Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. | Directeur/Membre du Conseil | 22/02/2024 | - |
| Independent Dir/Board Member | 22/02/2024 | - |
Historique de carrière de Lourdes Felix
Formation de Lourdes Felix
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 8 |
| Canada | 2 |
| Chine | 2 |
Opérationnelle
| Director/Board Member | 7 |
| Independent Dir/Board Member | 5 |
| Chief Operating Officer | 2 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BIOCORRX INC. | Health Services |
| SIYATA MOBILE INC. | Electronic Technology |
| LICHEN CHINA LIMITED | Commercial Services |
| AVALON GLOBOCARE CORP. | Health Technology |
 | Technology Services |
| LA ROSA HOLDINGS CORP. | Finance |
| Entreprise privées | 1 |
|---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Bourse
- Insiders
- Lourdes Felix
- Expérience
